Emmaus Life Sciences, Inc. (EMMA) Reports Q1 Loss of $0.04

Emmaus Life Sciences, Inc. (OTC: EMMA) reported Q1 EPS of ($0.04). Revenue for the quarter came in at $2.4 million.

For earnings history and earnings-related data on Emmaus Life Sciences, Inc. (EMMA) click here.

You May Also Be Interested In

• Stardust Power (SDST) Tops Q2 EPS by 1c
• Needham Reiterates Buy Rating on Digimarc (DMRC)
• Raymond James Starts SpyGlass Pharma (SGP) at Outperform